This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun 19;8(6):e2948.
doi: 10.1371/journal.pntd.0002948. eCollection 2014 Jun.

Mechanisms of pyrethroid resistance in the dengue mosquito vector, Aedes aegypti: target site insensitivity, penetration, and metabolism

Affiliations

Mechanisms of pyrethroid resistance in the dengue mosquito vector, Aedes aegypti: target site insensitivity, penetration, and metabolism

Shinji Kasai et al. PLoS Negl Trop Dis. .

Abstract

Aedes aegypti is the major vector of yellow and dengue fevers. After 10 generations of adult selection, an A. aegypti strain (SP) developed 1650-fold resistance to permethrin, which is one of the most widely used pyrethroid insecticides for mosquito control. SP larvae also developed 8790-fold resistance following selection of the adults. Prior to the selections, the frequencies of V1016G and F1534C mutations in domains II and III, respectively, of voltage-sensitive sodium channel (Vssc, the target site of pyrethroid insecticide) were 0.44 and 0.56, respectively. In contrast, only G1016 alleles were present after two permethrin selections, indicating that G1016 can more contribute to the insensitivity of Vssc than C1534. In vivo metabolism studies showed that the SP strain excreted permethrin metabolites more rapidly than a susceptible SMK strain. Pretreatment with piperonyl butoxide caused strong inhibition of excretion of permethrin metabolites, suggesting that cytochrome P450 monooxygenases (P450s) play an important role in resistance development. In vitro metabolism studies also indicated an association of P450s with resistance. Microarray analysis showed that multiple P450 genes were over expressed during the larval and adult stages in the SP strain. Following quantitative real time PCR, we focused on two P450 isoforms, CYP9M6 and CYP6BB2. Transcription levels of these P450s were well correlated with the rate of permethrin excretion and they were certainly capable of detoxifying permethrin to 4'-HO-permethrin. Over expression of CYP9M6 was partially due to gene amplification. There was no significant difference in the rate of permethrin reduction from cuticle between SP and SMK strains.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Log dose-probit mortality lines of Aedes aegypti.
(A) The development of permethrin resistance in a field-collected population of adult A. aegypti under laboratory selection conditions. SPS0 is a field-collected population prior to permethrin selection. SPS10 is the strain established by permethrin selection for 10 generations and is designated as SP. SMK is a susceptible reference strain. (B) Dose–mortality lines of adult F1 (SP ×ばつ SMK or SMK ×ばつ SP) and BC1 (F1 ×ばつ SMK or SMK ×ばつ F1) showing the inheritance of SP resistance. (C) Synergistic effects of PBO on permethrin toxicity in adults. (D) Susceptibility of larvae to permethrin and the synergistic effects of PBO.
Figure 2
Figure 2. In vivo distribution of [14C]-permethrin topically applied to SP and SMK strains of Aedes aegypti.
(A) Schematic of the procedure of in vivo assay. (B) Percentage of the applied radiolabel recovered in the external rinse. [14C]-Permethrin (600 dpm; 0.88 ng) was applied to the thoracic notum. PBO (5 μg) was also applied to the thoracic notum or thoracic sternum 1 h prior to permethrin application to observe its effect on permethrin penetration. Acetone was also applied 1 h prior to permethrin application to confirm whether the solvent had any side effects. Values are expressed as the means (±SE) for four mosquitoes. (C) Percentage of radioactivity detected in the mosquitoes. (D) Percentage of radioactivity excreted in the vials. (E) Thin-layer chromatogram of the compounds excreted by females of SP strain. Developing solvents: toluene/ethyl acetate (6∶1). The presence of 4′-HO-permethrin was determined by co-chromatography with an authenticated chemical. (F) Percentage of permethrin and its metabolites excreted by females of SP strain. Values represent the average and bars represent the SE of the mean (n = 3). (G) Re-chromatography of the high-polar compounds stuck around origin. Developing solvents: chloroform/methanol/water (65∶25∶4).
Figure 3
Figure 3. In vitro [14C]-permethrin metabolism studies.
(A) Thin-layer chromatogram of in vitro permethrin metabolism in adult Aedes aegypti with or without NADPH or PBO. Microsomes (100,000 ×ばつ g pellet) and the soluble fraction (100,000 ×ばつ g supernatant) were used as the enzyme source. The presence of 4′-HO-permethrin was determined by co-chromatography with an authenticated chemical. (B) Metabolites of permethrin in adult A. aegypti at various incubation times. For detailed data, see Table S2. (C) Thin-layer chromatogram of high-polar compounds (SP) located at the origin of the first HPTLC. Developing solvents: chloroform/methanol/water (65∶25∶4). (D) Inhibition of permethrin metabolism by 4′-HO-permethrin. Microsomes of the SP strain were incubated for 30 min with [14C]-permethrin, NADPH, and ×ばつ7-, ×ばつ70-, or ×ばつ140-fold higher doses of 4′-HO-permethrin than permethrin.
Figure 4
Figure 4. Microarray screening of cytochrome P450 and b5 genes differentially expressed in SP and SMK strains.
Differential transcription of cytochrome P450 and b5 genes was individually investigated in adult female (A, B), adult male (C, D), and fourth instar larvae (E, F) of Aedes aegypti. Figures 4A–C show volcano plots of the relative changes (log2, x-axis) and statistical significance (–log10(P-value), y-axis). Figures 4D–F show scatter plots of the relative expression level of each P450 and b5 gene. Genes with relative expression >3-fold and a P-value<0.01 are highlighted.
Figure 5
Figure 5. Real time quantitative PCR analysis of selected genes from the microarray experiments.
Transcription levels of seven P450 genes were individually validated in adult female (A), adult male (B), and fourth instar larvae (C) in SP and SMK strains of Aedes aegypti. Ribosomal protein S3 gene (RPS3) was used to normalize the data. Expression ratios (SP/SMK) are expressed in parentheses. (D) Correlation between the microarray and real time quantitative PCR (R2 = 0.824). (E) Gene copy number of 7 P450s and RPS3 quantified by real time PCR. The ratios of relative copy number (SP/SMK) are expressed in parentheses. (F) Gene clusters of cytochrome P450 and the CYP9M subfamily on the A. aegypti supercontig 1.29 on the 2nd chromosome. The error bars represent standard errors of three (A, B, and C) and eight (E) biological replicates.
Figure 6
Figure 6. Genotype–gene expression–phenotype associations.
The association between CYP9M6/CYP6BB2 genotypes and mRNA expression and permethrin excretion rate was investigated. The female F2 populations of SP and SMK strains were dosed with [14C]-permethrin, and the amount of permethrin excreted was individually quantified 24 h after treatment. The genotype of each mosquito was identified by the genomic DNA isolated from six legs. mRNA level was also quantified with RNA isolated from the body part of each mosquito. For more information, see Materials and Methods. (A, D) Plot showing the association between the level of mRNA and permethrin excretion in CYP9M6 (A) and CYP6BB2 (D). (B, E) Box plot showing the association between mRNA level and CYP9M6 (B) and CYP6BB2 (E). (C, F) Box plot showing the association between permethrin excretion rate and genotype of CYP9M6 (C) and CYP6BB2 (F). P-values for comparison of the RR and SS genotypes were calculated using Dunnett's test.
Figure 7
Figure 7. Associations between the gene expression level of six P450s and permethrin excretion rate.
The female F2 populations of SP and SMK strains were dosed with [14C]-permethrin and the amount of permethrin excreted by each insect was quantified 24 h after treatment. The level of mRNA was quantified using RNA isolated from each mosquito. For more information, see Materials and Methods. (A) CYP6BB2, (B) CYP6Z7, (C) CYP6Z8, (D) CYP9M4, (E) CYP9M5, and (F) CYP9M6. Forty-eight individuals were ranked from 1 to 48 according to the level of expression of each P450 gene. The ranks against multiple P450 genes were combined to standardize the level of mRNA and evaluate the association between permethrin excretion rate and expression level of multiple P450 genes. (G) Association between permethrin excretion and standardized level of mRNA for CYP6BB2 and CYP9M6. (H) Association between permethrin excretion rate and standardized level of mRNA for CYP6BB2, CYP9M6 and CYP9M5. (I) Association between permethrin excretion rate and standardized level of mRNA for CYP6BB2, CYP6Z7, CYP6Z8, CYP9M4, CYP9M5, and CYP9M6.
Figure 8
Figure 8. Thin layer chromatogram of [14C]-permethrin metabolites by heterologously expressed CYP9M6v1, CYP9M6v2, and CYP6BB2.
A-E denote unidentified metabolites. Developing solvents: toluene/ethyl acetate (6∶1). The presence of 4′-HO-permethrin was determined by co-chromatography with an authenticated chemical.
Figure 9
Figure 9. Proposed model showing the metabolic pathway of permethrin.

References

    1. Mackenzie JS, Gubler DJ, Petersen LR (2004) Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 10: S98–S109. - PubMed
    1. Gubler DJ (2002) Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 10: 100–103. - PubMed
    1. Gubler DJ, Clark GG (1995) Dengue/dengue hemorrhagic fever: the emergence of a global health problem. Emerg Infect Dis 1: 55–57. - PMC - PubMed
    1. Whitehorn J, Farrar J (2010) Dengue. Br Med Bull 95: 161–173. - PubMed
    1. Gubler DJ (1998) Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 11: 480–496. - PMC - PubMed

Publication types

LinkOut - more resources

Cite

AltStyle によって変換されたページ (->オリジナル) /